Request Call Back

Contact Us

Blood Clots
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Please describe blood clots:

If you believe the blood clots developed as the result of a drug, please list drug:

   * Please describe your case:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Blood Clots

Blood Clots Disease Injury Lawsuits

Blood Clots | Lawsuits, Lawyers | Disease: Injury, Infection | Side Effects, Prescription Drugs, Medications, HRT drugs, COX-II Inhibitors, Ortho Evra Patch

On November 10, 2005 Johnson & Johnson's Ortho McNeil unit issued a warning that the Ortho Evra contraceptive patch contains higher levels of a hormone known to cause blood clots than average birth control pills. Women who use Ortho Evra are exposed to 60 percent more estrogen than those who use the pill, the FDA said in a statement. The warning comes after several investigative reports by The Associated Press and CBS News highlighted the risks of Ortho Evra.

The Associated Press reported that it appears that the risk of dying or suffering a survivable blood clot while using the Ortho Evra birth control patch was about three times higher than while using birth control pills. The AP found that the FDA and and Ortho-McNeil were aware of the increased risk of blood clots associated with the patch even before it was approved. According to FDA reports obtained by the Associated Press, a dozen women died last year from blood clots believed to be related to the Ortho Evra patch.

FDA records show that seventeen patch users between the ages of 17 and 30 have suffered fatal heart attacks, blood clots and possible strokes since August 2002. Blood clots are masses of thickened blood. Clotting is a means used by the body to end bleeding.

The first stage in clotting is adhesion of platelets, which are fragments of blood cells that travel in the blood, to the cut edges of a damaged blood vessel. As a result, a platelet plug is formed and external bleeding stops. Next, small molecules, called clotting factors, cause strands of materials, (fibrin) to stick together and seal the inside of the wound. Eventually, the cut blood vessel heals and the blood clot dissolves after a few days. A blood clot can become dangerous when it blocks an artery or vein and stops blood flow.

The blood clot is then called a thrombus. Although a thrombus may occur in any blood vessel, it most commonly develops in the veins of the leg and can travel through the major blood vessels of the pelvis and lung where it can be fatal. A thrombus in the leg or pelvic vein is called a deep vein thrombosis (DVT). A thrombus that breaks free and travels within the bloodstream it is called an embolus. As it travels, it compromises blood flow and may become lodged in a smaller blood vessel, causing blockage.

For example, if an embolus blocks an artery in the lung, it is called a pulmonary embolism. Common symptoms of a pulmonary embolus include: shortness of breath, chest pain and coughing up blood. Common signs of a DVT include: pain in the calf or leg muscle, swelling, tenderness, prominent veins and discoloration.

Less common symptoms may include: back , shoulder or upper abdomen pain; dizziness; fainting; painful respiration; wheezing;  new heart arrhythmias. An embolism can also travel to the heart, eyes, or brain. An em-bolus in the brain can cause strokes. An em-bolus blocking an artery in the heart can cause heart attacks. An em-bolus may cause sudden blindness in one eye. An em-bolus that blocks an artery is a life- threatening condition. There are many factors that increase the risk of blood clots: Atypical Antipsychotic Drugs, HRT Drugs, Ortho Evra contraceptive patch, bed rest, chemotherapy, deep vein thrombosis, fractures, birth control pills, smoking and cancer.

Legal Help For Victims Affected By Blood Clots

If you or a loved one has taken HRT drugs, COX-II Inhibitors or used the Ortho Evra Patch and been diagnosed with Blood clots, please fill out the form at the right for a free case evaluation by a qualified defective drug attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


Blood ClotsRSS Feed

FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)

Mar 9, 2007 |
The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information, including revised product labeling about erythropoiesis-stimulating agents (ESAs), widely-used drugs for the treatment of anemia. The drugs affected by the safety update are darbepoetin alfa (Aranesp) and epoetin alfa (Epogen and Procrit). (ESAs are genetically engineered forms of the naturally occurring human protein, erythropoietin. Natural erythropoietin is made by the kidney...

FDA Warns of Serious Side Effects Related to Popular Anemia Drugs

Mar 9, 2007 |
FDA Warns of Serious Side Effects Related to Popular Anemia DrugsThe U.S. Food and Drug Administration (FDA) has issued a new warning about erythropoiesis-stimulating agents (ESAs), which are drugs that are used to treat anemia. The warnings relate to darbepoetin alfa (Aranesp) and epoetin alfa (Epogen and Procrit). All three of the drugs are made by Amgen Inc., although Procrit is distributed and marketed by a Johnson & Johnson subsidiary. “Recently completed studies describe an...

Stent research alarms patients

Feb 26, 2007 | The Morning Call
John Wehr couldn't believe what was he was reading. An article on drug-coated stents, the kind used to prop open his two clogged coronary arteries last June, said the devices have a ''small but significantly increased risk'' of life-threatening side-effects. Worried, the 78-year-old retired Bethlehem Steel Corp. accountant clipped the article and called his cardiologist. He wasn't alone. Drug-coated stents tiny mesh tubes coated in chemotherapy drugs have been considered the best medicine had...

Study: Contraceptive Patch Increases Risk of Blood Clots

Feb 26, 2007 |
According to a study published this month in the journal Obstetrics & Gynecology, women who use contraceptive patches, such as Ortho Evra, may be more than twice as susceptible to blood clotting as women who take oral contraception. The study was conducted by researchers at the i3 Drug Safety group. The study looked at more than 98,000 women who’ve used transdermal (patch) contraception and compared them with more than 250,000 women who’ve used oral contraception; the median...

Parker Waichman LLP Believes New Study Confirms Ortho Evra is Associated with Increased Risk of Venous Thromboembolism Compared to Oral Contraceptive Pills

Feb 23, 2007 | PrimeZone
Parker Waichman LLP ( announced today that they believe the results of a new study, which appears in the February edition of Obstetrics & Gynecology, confirms that the Ortho Evra transdermal contraceptive patch is more dangerous than oral contraceptive pills. The study, which analyzed United Healthcare insurance claims from April 2002 to December 2004, found a more than 200 percent increase in the rate of venous thromboembolism among women using Ortho Evra compared with...

More Blood Clots News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo